[ORGANIZATION]
David Geffen School of Medicine at UCLA
Featured in 5 tracked stories · first seen
Also covered in
-
Oxaloacetate supplement may reduce brain fog in breast cancer survivors
[HEALTH] · 3 sources ·
-
UCLA study: Radioligand therapy delays recurrent prostate cancer progression
[HEALTH] · 2 sources ·
-
UCLA receives $3.9M NIH grant to advance cancer immunotherapy
[HEALTH] · 3 sources ·